{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:19:54Z","timestamp":1761895194345},"reference-count":38,"publisher":"Hindawi Limited","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1754,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1111\/j.1365-2710.2010.01217.x","type":"journal-article","created":{"date-parts":[[2010,11,12]],"date-time":"2010-11-12T06:26:32Z","timestamp":1289543192000},"page":"592-601","source":"Crossref","is-referenced-by-count":10,"title":["Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients"],"prefix":"10.1155","volume":"36","author":[{"given":"G.","family":"Derosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Maffioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Randazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"D\u2019Angelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. F. G.","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2010,11,12]]},"reference":[{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1053\/j.gastro.2007.03.052","article-title":"The epidemiology of obesity","volume":"132","author":"Ogden","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1024\/0300-9831.76.4.172","article-title":"From obesity to diabetes","volume":"76","author":"Keller","year":"2006","journal-title":"International Journal for Vitamin and Nutrition Research"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB3|cit3","first-page":"88","article-title":"Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)","volume":"28","author":"Ryd\u00e9n","year":"2007","journal-title":"European Heart Journal"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2337\/diacare.27.2007.S58","article-title":"Physical activity\/exercise and diabetes","volume":"27","author":"American Diabetes Association","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"68B","DOI":"10.1016\/j.amjcard.2006.11.007","article-title":"Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction","volume":"99","author":"Lee","year":"2007","journal-title":"American Journal of Cardiology"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(07)60033-6","article-title":"Drug treatments for obesity: orlistat, sibutramine, and rimonabant","volume":"369","author":"Padwal","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archinte.164.9.994","article-title":"The efficacy and safety of sibutramine for weight loss: a systematic review","volume":"164","author":"Arterburn","year":"2004","journal-title":"Archives of Internal Medicine"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0140-6736(00)03491-7","article-title":"Effect of sibutramine on weight maintenance after weight loss: a randomized trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance","volume":"356","author":"James","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa050156","article-title":"Randomized trial of lifestyle modification and pharmacotherapy for obesity","volume":"353","author":"Wadden","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1463-1326.2000.00071.x","article-title":"Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study","volume":"2","author":"Finer","year":"2000","journal-title":"Diabetes, Obesity & Metabolism"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1463-1326.2005.00481.x","article-title":"Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patients","volume":"8","author":"Finer","year":"2006","journal-title":"Diabetes, Obesity & Metabolism"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB12|cit12","volume-title":"Obesity: preventing and managing the global epidemic","author":"World Health Organization","year":"1997"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1161\/01.ATV.0000238352.25222.5e","article-title":"Summary of American Heart Association Diet and Lifestyle Recommendations revision","volume":"26","author":"Lichtenstein","year":"2006","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB14|cit14","article-title":"Effects of combination of sibutramine and L-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients","author":"Derosa","year":"2010","journal-title":"Metabolism"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB15|cit15","volume-title":"Statistical principles in experimental design","author":"Winer","year":"1971"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.metabol.2008.06.010","article-title":"Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone","volume":"57","author":"Derosa","year":"2008","journal-title":"Metabolism"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2169\/internalmedicine.48.1670","article-title":"Pioglitazone metabolic effect in metformin-intolerant obese patients treated with sibutramine","volume":"48","author":"Derosa","year":"2009","journal-title":"Internal Medicine"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB18|cit18","volume-title":"Obesity: preventing and managing the global epidemic","author":"World Health Organization","year":"2000"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/j.1550-8528.1999.tb00701.x","article-title":"Sibutramine produces dose-related weight loss","volume":"7","author":"Bray","year":"1999","journal-title":"Obesity Research"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0002-9343(98)00411-2","article-title":"Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine","volume":"106","author":"Apfelbaum","year":"1999","journal-title":"American Journal of Medicine"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000047310","article-title":"Randomized, double-blind, placebocontrolled, multicenter study of sibutramine in obese hypertensive patients","volume":"94","author":"Hazenberg","year":"2000","journal-title":"Cardiology"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2337\/diacare.26.1.125","article-title":"A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin","volume":"26","author":"McNulty","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB23|cit23","first-page":"2537","article-title":"Characteristics of dysfunction of islet beta-cell in newly diagnosed type 2 diabetic patients","volume":"86","author":"Li","year":"2006","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0092-8674(03)01081-X","article-title":"Obesity wars: molecular progress confronts an expanding epidemic","volume":"116","author":"Flier","year":"2004","journal-title":"Cell"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/39335","article-title":"Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function","volume":"389","author":"Uysal","year":"1997","journal-title":"Nature"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1365-2796.1999.00490.x","article-title":"The role of TNF-alpha and TNF receptors in obesity and insulin resistance","volume":"245","author":"Hotamisligil","year":"1999","journal-title":"Journal of Internal Medicine"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/CS20050243","article-title":"Neuroendocrine and metabolic effects of adipocyte-derived hormones","volume":"110","author":"Jackson","year":"2006","journal-title":"Clinical Science"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1043-2760(01)00524-0","article-title":"ACRP30\/adiponectin: an adipokine regulating glucose and lipid metabolism","volume":"13","author":"Berg","year":"2002","journal-title":"Trends in Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1038\/sj.ijo.0802908","article-title":"Adiponectin: a relevant player in PPAR\u03b3-agonist mediated improvements in hepatic insulin sensitivity?","volume":"29","author":"Bouskila","year":"2005","journal-title":"International Journal of Obesity and Related Metabolic Disorders"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nm724","article-title":"Diet-induced insulin resistance in mice lacking adiponectin\/ACRP30","volume":"8","author":"Maeda","year":"2002","journal-title":"Nature Medicine"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nature Medicine"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/90992","article-title":"The adipocyte-secreted protein Acrp30 enhances hepatic insulin action","volume":"7","author":"Berg","year":"2001","journal-title":"Nature Medicine"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"10610","DOI":"10.1073\/pnas.0504703102","article-title":"Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity","volume":"102","author":"Hida","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/01.CIR.103.9.1194","article-title":"C-reactive protein-mediated lipoprotein uptake by macrophages","volume":"103","author":"Zwacka","year":"2001","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1463-1326.2004.00372.x","article-title":"Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients","volume":"7","author":"Derosa","year":"2005","journal-title":"Diabetes, Obesity & Metabolism"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB37|cit37","first-page":"222","article-title":"Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients","volume":"17","author":"Derosa","year":"2004","journal-title":"Diabetes, Nutrition & Metabolism"},{"key":"10.1111\/j.1365-2710.2010.01217.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMoa1003114","article-title":"Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects","volume":"363","author":"James","year":"2010","journal-title":"New England Journal of Medicine"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2710.2010.01217.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2710.2010.01217.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:03:57Z","timestamp":1671818637000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2710.2010.01217.x"}},"subtitle":["Sibutramine on inflammatory parameters"],"short-title":[],"issued":{"date-parts":[[2010,11,12]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2710.2010.01217.x","relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11,12]]}}}